Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Virtus Investment Advisers Inc. Buys Shares of 2,040 CBRE Group, Inc. (NYSE:CBRE)
Virtus Investment Advisers Inc. bought a new position in shares of CBRE Group, Inc. (NYSE:CBRE – Free Report) during the...
GitLab (NASDAQ:GTLB) Updates Q4 Earnings Guidance
GitLab (NASDAQ:GTLB – Get Free Report) issued an update on its fourth quarter earnings guidance on Thursday morning. The company...
Kovitz Investment Group Partners LLC Buys 57,069 Shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR)
Kovitz Investment Group Partners LLC raised its holdings in shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR – Free Report)...
AeroVironment (NASDAQ:AVAV) Issues FY 2025 Earnings Guidance
AeroVironment (NASDAQ:AVAV – Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of...
Sapiens International (NASDAQ:SPNS) Receives “Market Perform” Rating from William Blair
Sapiens International (NASDAQ:SPNS – Get Free Report)‘s stock had its “market perform” rating restated by equities researchers at William Blair...
iShares Bitcoin Trust (NASDAQ:IBIT) Shares Up 0.6% – Time to Buy?
iShares Bitcoin Trust (NASDAQ:IBIT – Get Free Report)’s stock price traded up 0.6% during mid-day trading on Wednesday . The...